The most important issues in pancreatic imaging are the detection and staging of pancreatic cancer, differentiation between cancer and focal pancreatitis, the characterization of cystic lesions and the search for neuroendocrine tumours. Magnetic resonance (MR) units (1.5 T) with strong gradients and a phased-array torso coil should be used, making breath-hold imaging possible in order to avoid motion artifacts. Standard imaging sequences are T1-weighted (T1w) gradient recalled-echo (GRE) with and without fat saturation. For T2-weighted (T2w) imaging, axial single-shot turbo spin-echo (TSE) and coronal/oblique MR cholangio-pancreatography (MRCP) pulse sequences are preferable. As contrast agents either gadolinium agents or mangafodipir trisodium are used. Dynamic gadolinium-enhanced T1w fatsat 3D GRE images are helpful to delineate vessel infiltration by adenocarcinoma and to assess the aetiology of cystic masses. Mangafodipir-enhanced MRI has been found to be superior to helical computed tomography (CT) in the detection of small cancers and in the delineation of liver metastases. In cases of an equivocal pancreatic mass the presence of the ``duct penetrating sign'' at MRCP (i.e., the duct traversing the mass) is suggestive of an inflammatory pseudotumour. Hypoattenuation due to focal fatty infiltration may mimic a tumour at CT, but in-phase and opposedphased T1w imaging readily depicts the fat. Multi-detector CT has gained increasing popularity for pancreatic imaging because of the 3D visualization of the peripancreatic vessels. However, MR imaging is excellent in the delineation of small pancreatic tumours. Due to its superior soft tissue contrast, MR imaging is also the method of choice in the differential diagnosis between tumours and tumour-simulating conditions in patients with equivocal CT and to assess cystic lesions.

Author

Wolfgang Schima

Contact Details

Corresponding address:
Prof Dr Wolfgang Schima, MSc,
Department of Radiology,
Medical University of Vienna,
Wearing Guertel 18-20,
A-1090 Vienna, Austria

Reference

ICIS Cancer Imaging Volume 6 Issue 1
DOI: 10.1102/1470-7330.2006.0035

Date Posted

20 December 2006

Print PDF

Size

4.96 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	19 seconds
ADSL 512Kb/s (Broadband):	1 minute 19 seconds
64 Kb/s (ISDN):	10 minutes 34 seconds
33.3 Kb/s (Typical Modem):	20 minutes 19 seconds

Screen PDF

Size

542.50 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	2 seconds
ADSL 512Kb/s (Broadband):	8 seconds
64 Kb/s (ISDN):	1 minute 7 seconds
33.3 Kb/s (Typical Modem):	2 minutes 10 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 231 7773 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.